22 hours ago | News
Watson Pharmaceuticals Inc. said Wednesday it settled a patent lawsuit brought by a unit of Johnson & Johnson over a generic version of the birth control drug Ortho Tri-Cyclen Lo.
|
Feb 8 | News
Sanofi and Bristol-Myers Squibb Company announced today that Apotex has made payment in the amount of $442,209,362 to Sanofi and Bristol-Myers Squibb to satisfy the damages ruling of the Plavix(R) (clopidogrel bisulfate) patent infringement case against Apotex.
|
Jan 25 | News
A European Union high court ruled on Wednesday that the name Viaguara cannot be registered as an EU trademark for energy and alcoholic drinks because it is too similar to the impotence pill Viagra.
|
Jan 24 | News
Johnson & Johnson said Tuesday that fourth-quarter profit was barely a tenth of what it made a year ago as several charges for recalls, litigation and an acquisition dragged down income.
|
Jan 23 | News
The Medicines Company today announced that it has settled the lawsuits filed by MDCO in the U.S. District Court for the District of Delaware relating to the Abbreviated New Drug Application (ANDA) filed by APP Pharmaceuticals, LLC (APP) for a generic version of Angiomax (bivalirudin for injection).
|
Jan 20 | News
BOSTON (AP) — A federal judge in Boston has ordered 14 drug companies to negotiate settlements for 53 women who claim their breast cancer was caused by an anti-miscarriage drug their mothers took decades ago.
|
Jan 18 | News
TRENTON, N.J. (AP) — A former research chemist in the New Jersey office of Sanofi-Aventis has pleaded guilty to one count of stealing trade secrets from her former employer.
|
Jan 3 | News
Regeneron Pharmaceuticals, Inc. today announced that the company has entered into a non-exclusive license and partial settlement agreement with Genentech, Inc., a member of the Roche Group relating to U.S. ophthalmic sales of EYLEAT (aflibercept) Injection.
|
Dec 22 2011 | News
NEW YORK (AP) — A French doctor who cooperated in a New York-based probe of insider trading in pharmaceutical stocks will not have to serve any more prison time.
|
Dec 19 2011 | News
SYDNEY (AP) — Members of an Australian class action lawsuit who blame a German pharmaceutical company's anti-morning sickness drug, Thalidomide, for causing birth defects won the right on Monday to have their case heard in their own country.
|